D'Acierno Mariavittoria, Fenton Robert A, Hoorn Ewout J
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Nephrol Dial Transplant. 2025 Apr 1;40(4):632-640. doi: 10.1093/ndt/gfae235.
Water homeostasis is controlled by a brain-kidney axis that consists of central osmoreceptors, synthesis and secretion of arginine vasopressin (AVP) and AVP-responsive aquaporin-2 (AQP2) water channels in kidney collecting duct principal cells that facilitate water reabsorption. In addition to AVP, thirst represents a second line of defence to maintain water balance. Water balance disorders arise because of deficiency, resistance or inappropriate secretion of AVP or disturbances in thirst sensation (hypodipsia, polydipsia). People with water balance disorders are prone to develop hyponatraemia or hypernatraemia, which expose cells to osmotic stress and activate cell volume regulation mechanisms. This review covers several recent insights that have expanded our understanding of central osmoregulation, AQP2 regulation and cell volume regulation. This includes the role of with no lysine kinase 1 (WNK1) as a putative central osmolality sensor and, more generally, as an intracellular crowding sensor that coordinates the cell volume rescue response by activating sodium and potassium cotransporters. Furthermore, several new regulators of AQP2 have been identified, including AVP-dependent AQP2 regulation (yes-associated protein, nuclear factor of activated T-cells, microRNAs) and AVP-independent AQP2 regulation (epidermal growth factor receptor, fluconazole, prostaglandin E2). It is also becoming increasingly clear that long-term cell volume adaptation to chronic hypotonicity through release of organic osmolytes comes at the expense of compromised organ function. This potentially explains the complications of chronic hyponatraemia, including cognitive impairment, bone loss and vascular calcification. This review illustrates why these new insights derived from basic science are also relevant for developing new approaches to treat water balance disorders.
水稳态由脑-肾轴控制,该轴由中枢渗透压感受器、精氨酸加压素(AVP)的合成与分泌以及肾集合管主细胞中对AVP有反应的水通道蛋白-2(AQP2)水通道组成,这些水通道促进水的重吸收。除AVP外,口渴是维持水平衡的第二道防线。由于AVP缺乏、抵抗或分泌不当或口渴感觉紊乱(低渴感、烦渴),会出现水平衡失调。患有水平衡失调的人容易发生低钠血症或高钠血症,这会使细胞受到渗透压应激并激活细胞体积调节机制。本综述涵盖了一些最新见解,这些见解扩展了我们对中枢渗透调节、AQP2调节和细胞体积调节的理解。这包括无赖氨酸激酶1(WNK1)作为假定的中枢渗透压传感器的作用,更一般地说,作为一种细胞内拥挤传感器,通过激活钠钾共转运体来协调细胞体积挽救反应。此外,还发现了几种新的AQP2调节因子,包括依赖AVP的AQP2调节(Yes相关蛋白、活化T细胞核因子、微小RNA)和不依赖AVP的AQP2调节(表皮生长因子受体、氟康唑、前列腺素E2)。越来越清楚的是,通过释放有机渗透溶质使细胞体积长期适应慢性低渗状态是以器官功能受损为代价的。这可能解释了慢性低钠血症的并发症,包括认知障碍、骨质流失和血管钙化。本综述说明了为什么这些来自基础科学的新见解也与开发治疗水平衡失调的新方法相关。